Treatment of Recurrent Corneal Epithelial Defect by Autologous Serum Eye Drop

Background: The aim of the present study was to evaluate the efficacy of autologous serum eye drop in treatment of recurrent corneal epithelial defect. Materials and Methods: Fourteen patients with recurrent corneal epithelial defect were studied. Autologous serum was prepared from the patients and diluted in 20% normal saline. The patients were instructed to use the autologous serum every six hours. Patients were followed for a mean period of 18 months. Results: Four males (28.6%) and 10 females (71.4%) entered the study. Four patients stopped the treatment after three months with complete satisfaction from treatment. Patients reported a reduction in frequency and severity of attacks 4.6±2 weeks after the start of treatment. The mean number of attacks before the procedure was 7.6±0.9 per year which was reduced to 2.2±0.9 per year after treatment (p<0.001). The main side effects in patients were eye pruritus and redness which were well tolerated by patients. Conclusion: Autologous serum application seems to be a safe and effective method to treat recurrent corneal epithelial defect.

[1]  Frederick W. Fraunfelder,et al.  Treatment of Recurrent Corneal Erosion by Extended-wear Bandage Contact Lens , 2011, Cornea.

[2]  K. Hammersmith,et al.  Review of diagnosis and management of recurrent erosion syndrome , 2009, Current opinion in ophthalmology.

[3]  S. Pflugfelder.  Is autologous serum a tonic for the ailing corneal epithelium? , 2006, American journal of ophthalmology.

[4]  K. Tsubota,et al.  Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells , 2006, British Journal of Ophthalmology.

[5]  A. Tarkkanen,et al.  Epidermal growth factor is a constant component of normal human tear fluid , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  K. Tsubota,et al.  Autologous serum application in the treatment of neurotrophic keratopathy. , 2004, Ophthalmology.

[7]  T. Nishida,et al.  Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. , 2003, Investigative ophthalmology & visual science.

[8]  K. Tsubota,et al.  Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease , 2003, Bone Marrow Transplantation.

[9]  C. Creuzot-Garcher,et al.  Treatment of Persistent Corneal Epithelial Defects by Autologous Serum , 2002 .

[10]  J. Daniels,et al.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies , 2001, The British journal of ophthalmology.

[11]  M. Paulus,et al.  Recurrent Erosions of the Cornea: Epidemiology and Treatment , 2000, Cornea.

[12]  K. Tsubota,et al.  Treatment of persistent corneal epithelial defect by autologous serum application. , 1999, Ophthalmology.

[13]  K. Tsubota,et al.  Treatment of dry eye by autologous serum application in Sjögren’s syndrome , 1998, The British journal of ophthalmology.